Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

OBJECTIVE: To assess the utility and safety of rituximab in pediatric autoimmune and inflammatory disorders of the CNS. METHODS: Multicenter retrospective study. RESULTS: A total of 144 children and adolescents (median age 8 years, range 0.7–17; 103 female) with NMDA receptor (NMDAR) encephalitis (n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dale, Russell C., Brilot, Fabienne, Duffy, Lisa V., Twilt, Marinka, Waldman, Amy T., Narula, Sona, Muscal, Eyal, Deiva, Kumaran, Andersen, Erik, Eyre, Michael R., Eleftheriou, Despina, Brogan, Paul A., Kneen, Rachel, Alper, Gulay, Anlar, Banu, Wassmer, Evangeline, Heineman, Kirsten, Hemingway, Cheryl, Riney, Catherine J., Kornberg, Andrew, Tardieu, Marc, Stocco, Amber, Banwell, Brenda, Gorman, Mark P., Benseler, Susanne M., Lim, Ming
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117174/
https://ncbi.nlm.nih.gov/pubmed/24920861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000570
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars